Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Cullinan Oncology LLC stock

Learn how to easily invest in Cullinan Oncology LLC stock.

Cullinan Oncology LLC is a biotechnology business based in the US. Cullinan Oncology LLC shares (CGEM) are listed on the NASDAQ and all prices are listed in US Dollars. Cullinan Oncology LLC employs 37 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Cullinan Oncology LLC

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CGEM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Cullinan Oncology LLC stock price (NASDAQ: CGEM)

Use our graph to track the performance of CGEM stocks over time.

Cullinan Oncology LLC shares at a glance

Information last updated 2022-07-01.
Latest market close$12.93
52-week range$7.30 - $30.33
50-day moving average $11.28
200-day moving average $15.55
Wall St. target price$34.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.78

Buy Cullinan Oncology LLC shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you open a Robinhood account
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cullinan Oncology LLC stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cullinan Oncology LLC price performance over time

Historical closes compared with the close of $12.93 from 2022-07-01

1 week (2022-06-28) 3.86%
1 month (2022-06-06) 5.29%
3 months (2022-04-06) -0.31%
6 months (2022-01-06) -16.26%
1 year (2021-07-06) -48.73%
2 years (2020-07-02) N/A
3 years (2019-07-02) N/A
5 years (2017-07-02) N/A

Cullinan Oncology LLC financials

Gross profit TTM $18.9 million
Return on assets TTM -12.99%
Return on equity TTM -18.4%
Profit margin 0%
Book value $9.38
Market capitalisation $579 million

TTM: trailing 12 months

Cullinan Oncology LLC share dividends

We're not expecting Cullinan Oncology LLC to pay a dividend over the next 12 months.

You may also wish to consider:

Have Cullinan Oncology LLC's shares ever split?

Cullinan Oncology LLC's shares were split on a 2:1 basis on 30 August 2009. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Cullinan Oncology LLC shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Cullinan Oncology LLC shares which in turn could have impacted Cullinan Oncology LLC's share price.

Cullinan Oncology LLC overview

Cullinan Oncology Inc. , a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with non-small cell lung cancer. Its preclinical products include CLN-049, a humanized bispecific antibody for the treatment of acute myeloid leukemia; CLN-619, a monoclonal antibody for the treatment of solid tumors; CLN-617, a fusion protein for the treatment of solid tumors; CLN-978, a T cell engaging antibody for B-cell malignancies; Opal, a bispecific fusion protein to block the PD-1 axis, and to activate the 4-IBB/CD137 pathway on T cells in tumors; and Jade, a cell therapy to target a novel senescence and cancer-related protein. The company has collaboration agreements with Cullinan Pearl Corp. to develop, manufacture, and commercialize CLN-081 and products containing CLN-081; and Adimab, LLC to discover and/or optimize antibodies. Cullinan Oncology, Inc.

Frequently asked questions

What percentage of Cullinan Oncology LLC is owned by insiders or institutions?
Currently 17.972% of Cullinan Oncology LLC shares are held by insiders and 87.264% by institutions.
How many people work for Cullinan Oncology LLC?
Latest data suggests 37 work at Cullinan Oncology LLC.
When does the fiscal year end for Cullinan Oncology LLC?
Cullinan Oncology LLC's fiscal year ends in December.
Where is Cullinan Oncology LLC based?
Cullinan Oncology LLC's address is: One Main Street, Cambridge, MA, United States, 02142
What is Cullinan Oncology LLC's ISIN number?
Cullinan Oncology LLC's international securities identification number is: US2300311063

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site